Hollis, R.L.; Stillie, L.J.; Hopkins, S.; Bartos, C.; Churchman, M.; Rye, T.; Nussey, F.; Fegan, S.; Nirsimloo, R.; Inman, G.J.;
et al. Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma. Cancers 2021, 13, 5839.
https://doi.org/10.3390/cancers13225839
AMA Style
Hollis RL, Stillie LJ, Hopkins S, Bartos C, Churchman M, Rye T, Nussey F, Fegan S, Nirsimloo R, Inman GJ,
et al. Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma. Cancers. 2021; 13(22):5839.
https://doi.org/10.3390/cancers13225839
Chicago/Turabian Style
Hollis, Robert L., Lorna J. Stillie, Samantha Hopkins, Clare Bartos, Michael Churchman, Tzyvia Rye, Fiona Nussey, Scott Fegan, Rachel Nirsimloo, Gareth J. Inman,
and et al. 2021. "Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma" Cancers 13, no. 22: 5839.
https://doi.org/10.3390/cancers13225839
APA Style
Hollis, R. L., Stillie, L. J., Hopkins, S., Bartos, C., Churchman, M., Rye, T., Nussey, F., Fegan, S., Nirsimloo, R., Inman, G. J., Herrington, C. S., & Gourley, C.
(2021). Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma. Cancers, 13(22), 5839.
https://doi.org/10.3390/cancers13225839